Evidence map›Paper›PMID 42094486›Full record

ArticlebioRxiv : the preprint server for biology2026

SPPIDER-seq: Sequence-based partner-aware predictor of protein-protein interaction sites.

Aleksey Porollo, Om Jadhav, Aaron Alvarez, Jichao Chen

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Aleksey PorolloDepartment of Biostatistics, Health Informatics and Data Sciences, the University of Cincinnati College of Medicine, Cincinnati, OH, USA 45267.ORCID 0000-0002-3202-5099
Om JadhavDepartment of Computer Science, the University of Cincinnati College of Engineering and Applied Science, Cincinnati, OH, USA 45221.ORCID 0009-0007-6937-8465
Aaron AlvarezDepartment of Computer Science, the University of Cincinnati College of Engineering and Applied Science, Cincinnati, OH, USA 45221.ORCID 0009-0003-9036-9847
Jichao ChenDivision of Pulmonary Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA 45229.ORCID 0000-0003-2749-8550

Funding

Transcriptional and epigenetic mechanisms of alveologenesis and re-alveologenesisR35HL171346 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI Jichao Chen · 2024 to 2026
$3.3M
Elucidating the Sexual Cycle of HIV/AIDS-Related Pneumocystis PneumoniaR01HL176858 · NHLBI · UNIVERSITY OF CINCINNATI · PI Melanie T Cushion, Alexey Porollo · 2025 to 2026
$976k
NHLBI NIH HHS R01 HL176858NHLBI NIH HHS R35 HL171346
6 · The paper itself

Abstract

Motivation: Sequence-based protein-protein interaction (PPI) site predictors typically analyze proteins in isolation, neglecting partner-specific context that is critical for interface specificity, particularly in transient and disordered interactions. Results: We introduce SPPIDER-seq, a partner-aware PPI site prediction framework that combines pretrained ESM-2 embeddings with a cross-attention architecture to enable residue-level conditioning on interacting partners. We curated non-redundant protein-peptide interaction datasets from BioLiP and used them to train and benchmark two complementary models: a receptor-centric model optimized for structured interfaces and a peptide-centric model tailored to disordered, motif-driven binding. On blind benchmarks, SPPIDER-seq achieved AUROC values up to 0.797 and MCC values up to 0.269, outperforming AlphaFold3 on peptide-mediated and disordered interfaces while remaining complementary on globular complexes. Application to 341 TP53 interaction partners revealed coherent, partner-specific interface patterns across both structured and intrinsically disordered regions.

Identifiers

PMID42094486
PMCPMC13142516

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.